EMBARGOED FOR RELEASE UNTIL 4 PM ET, July 12, 2004
Neurology journal broadens recruitment efforts for clinical research trials
St. Paul, Minn. -
Clinical research trials are a key part of the process of developing new treatment therapies for numerous neurological disorders. Clinical trials need not just patients but patients that meet the strict eligibility requirements in well-designed controlled trials. With the July 13 issue, Neurology is introducing a new clinical trials recruiting section organized by disease. In the same issue, Neurology “Patient Page” editor Robin Brey, MD, a neurologist at the University of Texas in San Antonio, describes therapy advancements in stroke, epilepsy, Parkinson’s disease, multiple sclerosis and migraine that were dependent on clinical research trials. According to the Association of Clinical Research Professionals (www.acrpnet.org), close to 80 percent of clinical trials have problems in recruitment that delay or even prevent their completion. Information about clinical research studies for neurological diseases is available on the Neurology Website at www.neurology.org, and on the National Institute of Neurological Diseases and Stroke Website at www.nih.ninds.gov.